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Introduction
The term of macrophage activation syndrome (MAS)
refers to a condition caused by excessive activation and
expansion of T lymphocytes and macrophagic histiocytes
that exhibit hemophagocytic activity. The expansion of
these cells also leads to a massive systemic inflammatory
response associated with pan cytopenia, liver dysfunction,
and coagulopathy consistent by disseminated intravascular
coagulation (DIC).
MAS has been reported in association with almost any
rheumatic disease and most common in systemic onset
JIA. However, the pathological mechanisms of MAS are
not fully understood.
Objectives
In clinically similar primary HLH, the uncontrolled proli-
feration of T cells and macrophages has been linked to
decreased natural killer (NK) cell and cytotoxic T cell
function, often due to mutations in the gene encoding
perforin. Deficient cytotoxic function lead to Inefficient
apoptosis and overactivated macrophages.
Because high doses of LLO are known to cause cell
death by necrosis or apoptosis, we decided to evaluate the
effect of LLO on apoptosis of macrophages derived from
patients with macrophagea ctivation syndrome- In vitro.
Methods
Blood from MAS patients and healthy donors was
collected in Falcon tubes containing EDTA at 2 mM final
concentration and incubated with enrichment antibody
cocktail (50 µl per ml of whole blood) at room tempera-
ture for 20 minutes. Cells were then separated by density
gradient using Ficoll-Paque™ PLUS (GE Healthcare).
Platelets present in the enriched monocyte fraction were
discarded by 3 washing steps in PBS, 2% FBS. Finally,
monocytes were seeded in RPMI 10% FBS, 4 mM
L-Glutamine with Pen/Strep at a concentration of 5×105
cells/ml in 12-well tissue culture treated plates for 6 days.
The effects of various concentration of LLO ( 10%, 25%,
50%, 75% and more) were evaluated on apoptosis of
macrophages in both groups.
Results
By using LLO less than 75%, there were no apoptosis in
both normal and patients groups. However, 50% of macro-
phages of healthy donors and 82% of MAS patients
showed apoptosis by LLO 75% and more.
Conclusion
High concentrated LLO may induce significant apoptosis
in macrophages derived from patients with Macrophage




1Pediatric Rheumatology, Shahid Beheshti University of Medical Sciences,
Tehran, Iran, Islamic Republic Of. 2PIRC, Shahid Beheshti University of Medical
Sciences, Tehran, Iran, Islamic Republic Of. 3Immunology, Shahid Beheshti
University of Medical Sciences, Tehran, Iran, Islamic Republic Of.
1Pediatric Rheumatology, Shahid Beheshti University of Medical Sciences,
Tehran, Iran, Islamic Republic Of
Full list of author information is available at the end of the article
Shiari et al. Pediatric Rheumatology 2014, 12(Suppl 1):P215
http://www.ped-rheum.com/content/12/S1/P215
© 2014 Shiari et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Published: 17 September 2014
doi:10.1186/1546-0096-12-S1-P215
Cite this article as: Shiari et al.: Effect of listeriolysin O (LLO) secreted by
listeria monocytogenes on apoptosis of macrophages derived from
patients with macrophage activation syndrome- in vitro. Pediatric
Rheumatology 2014 12(Suppl 1):P215.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Shiari et al. Pediatric Rheumatology 2014, 12(Suppl 1):P215
http://www.ped-rheum.com/content/12/S1/P215
Page 2 of 2
